Profiel
Samuel Henderson is currently the Chief Scientific Officer at Cerecin, Inc. Previously, he worked as a Principal at The University of Colorado and as a Lead Scientist at Genoplex, Inc. He completed his undergraduate degree at the University of Washington and obtained his doctorate from the University of Chicago.
Actieve functies van Samuel Henderson
| Bedrijven | Functie | Begin |
|---|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Samuel Henderson
| Bedrijven | Functie | Einde |
|---|---|---|
Genoplex, Inc.
Genoplex, Inc. Packaged SoftwareTechnology Services Develops AI-powered technology platform to simplify the logistics of patient referrals for advanced therapies | Hoofd Techniek/Wetenschap/O&O | - |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Opleiding van Samuel Henderson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genoplex, Inc.
Genoplex, Inc. Packaged SoftwareTechnology Services Develops AI-powered technology platform to simplify the logistics of patient referrals for advanced therapies | Technology Services |
















